InterventionsHuman trial
Glucagon-Like Peptide 1 Receptor Agonist with Basal Insulin vs. Basal-Bolus Regimen on Glycemic Variability and Time-in-Range in Type 2 Diabetes Patients with Chronic Kidney Disease—A Randomised Controlled Trial
ADA Scientific Sessions 2025 Abstract
The paper
James Ling, Jack Kit‐Chung Ng, Aimin Yang, Elaine Chow
Show 5 more authors
Andrea O. Y. Luk, Alice P.S. Kong, Ronald C.W., Cheuk‐Chun Szeto, Juliana C.N. Chan,Hong Kong
ADA Scientific Sessions 2025 Abstract · 13 Jun 2025
Presented at ADA Scientific Sessions 2025 · Late-breaking 1973-LB
